在帕金森氏症患者中,缺食症和口腔喉勃拉迪基尼西亚
Fabrizio Stocchi1,2, Eleonora Annese3, Fabiana Radicati3,4
1Department of Neurology, Institute for Research and Medical Care San Raffaele Roma, via della Pisana 235, 00163, Rome, RM, Italy. fabrizio.stocchi@uniroma5.it.
Journal of neural transmission (Vienna, Austria : 1996)
|October 21, 2025
概括
在帕金森病 (PD) 中吞困难可能源于勃拉迪基尼西亚,而不是真正的消化障碍. 仔细评估和量身定制的治疗对于改善PD患者的生活质量至关重要.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
- 语音语言病理学 语言病理学
背景情况:
- 吞功能障碍或吞功能障碍在帕金森病 (PD) 中很常见,导致吸血,感染和生活质量降低.
- 了解PD中吞异常的潜在机制对于准确诊断和有效管理至关重要.
- 本综述侧重于病理生理学,临床表现和治疗策略,以治疗PD患者的吞问题.
研究的目的:
- 在帕金森病的背景下探索吞的机制.
- 分析吞异常的各个方面及其对PD患者生活质量的影响.
- 讨论PD相关的吞困难的潜在治疗方法.
主要方法:
- 关于吞机制和帕金森病研究的文献综述.
- 分析PD的运动症状 (如布拉迪基尼西亚和低运动症) 与吞功能之间的关系.
- 讨论临床评估方法和治疗干预措施.
主要成果:
- 真正的消化不良可能在PD中比通常认为的不那么普遍;许多症状与口腔大或舌头勃拉迪基尼西亚有关.
- 低运动,PD的一个关键运动症状,可以减缓肌肉运动,延长喉反射时间,并影响吞反射.
- 像吞困难,食物保留和依赖液体来帮助过境等症状可能表明布拉迪基尼西亚而不是消化不良.
结论:
- 在PD中吞异常需要仔细评估和精确的分类.
- 区分与布拉迪基尼西亚相关的症状和真正的失调症对于适当的治疗至关重要.
- 建议为个性化患者护理量身定制的药理疗法和饮食调整.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
972
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
972
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Deglutition
5.3K
Swallowing, otherwise known as deglutition, facilitates the transport of food from the mouth to the stomach. It is a multifaceted process that involves both the tongue and the muscles of the throat and esophagus. Saliva and mucus aid in this process, which takes approximately 4 to 8 seconds for semi-solid or solid food and around 1 second for liquids or very soft food.
Swallowing can be divided into three stages: the voluntary phase, the pharyngeal phase, and the esophageal phase. Although the...
Swallowing can be divided into three stages: the voluntary phase, the pharyngeal phase, and the esophageal phase. Although the...
5.3K
Gastrointestinal Motility Disorders
1.1K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.1K


